Establishing biomarkers for COVID-19 that indicate which patients are likely to develop severe disease could help clinicians to categorize patients earlier, improve prognosis and prioritize treatment.
Click here to find out more about Abcam’s SimpleStep ELISA® for blood biomarkers.
Labelled monoclonal antibodies analysed by mass spectrometry allow for quantitative multiplexing on intact tissue samples. This significant jump in the quantity of proteins detectable on a tissue sample is truly the next generation of IHC.
March 12, 2015 More +
Neurons and glia express unique sets of transcription factors, enzymes, cytoskeletal proteins and receptors. Ensure you are choosing the best neural subtype markers with Abcam easy-to-use guides.
July 11, 2019 More +
Call us on: + 961 1 39 66 77
